Richard A. Graham - 14 Mar 2023 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
SVP, RESEARCH & DEVELOPMENT
Signature
/s/ Corinna Liebowitz, Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
14 Mar 2023
Net transactions value
-$23,973
Form type
4
Filing time
16 Mar 2023, 19:04:18 UTC
Previous filing
08 Mar 2023
Next filing
18 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Sale $23,973 -2,323 -0.62% $10.32 371,817 14 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22.